London, May 7th – Ailurus, a leading company in programming biology, is excited to announce the launch of its startup plan for PandaPure, a revolutionary technology that streamlines protein expression and purification. This initiative is designed to support early-stage startups in the biotechnology sector, providing them with advanced tools to accelerate their research and development efforts.
Through this program, eligible startups who purchase PandaPure toolkits can request an additional license for commercial purposes without extra fee, allowing them to manufacture bioproducts and provide fee-for services to third parties. This offering enables startups to explore commercial applications with the financial burden of licensing fees or royalty shares, as long as the company continues to meet the criteria.
To qualify for the startup plan, companies must meet the following criteria:
- Have fewer than 50 employees
- Aggregate funding of $25 million or less
- Annual recurring revenue (ARR) of $1 million or less
"Recombinant proteins represent a significant portion of bioproducts in the market, from biologics for therapeutics to biocatalysts for green chemistry," said Dr. Haotian Guo, the CEO of Ailurus. "With our startup plan, we aim to democratize access to this cutting-edge technology, empowering early-stage startups to drive innovation in the bioeconomy."
Key benefits of PandaPure include:
1. Easy expression of a wide range of difficult proteins
2. Significant reduction in the cost and complexity of protein purification
To learn more about PandaPure technology and the free startup plan, please visit PandaPure website.
Ailurus Bio is a pioneering company building bioprograms, which are genetic codes that act as living software to instruct biology. We develop foundational DNAs and libraries to turn lab-grown cells into living instruments that streamline complex procedures in biological research and production. We offer these bioprograms to scientists and developers worldwide, empowering a diverse spectrum of scientific discovery and applications. Our mission is to make biology a general-purpose technology, as easy to use and accessible as modern computers, by constructing a biocomputer architecture for all.
This year, Ailurus is participating in SynBioBeta as a sponsor again. On May 7th, Ailurus' CEO Dr. Haotian Guo will kick off a discussion on how we can harness the power of biology for smarter design and even artificial intelligence, entitled Biocomputers: Transforming Our Work with Smarter Biology, in the Main Stage.
SynBioBeta attendees can also visit Ailurus at Booth #407 in the Main Exhibit Hall, where they can discover more details about the groundbreaking advances in synthetic cells and its application in protein expression and purification, Ailurus' latest product PandaPure. PandaPure offers next-level experiences of protein research, by eliminating the need for traditional chromatography, buffer exchange and protease treatments, and improving expression of many difficult proteins, which has a great potential to revolutionise the manufacturing of biologics, biocatalysts, and facilitating fundamental research, drug discovery and development, and AI-native data-intensive studies.
